WARREN, N.J., May 2, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens will be presenting and exhibiting at the 2017 Food Safety Summit. The conference will at the Donald Stevens Convention Center in Rosemont, Illinois from May 8-11th.
Dr. Erin Dreyling, Vice President of Research and Scientific Affairs for Roka Bioscience will present “Why Does a Better Pathogen Test Matter?” on Wednesday, May 10th from 12:00 -12:30 at the Solutions Stage Theater 1. This presentation will highlight the pivotal role pathogen testing plays in the development of effective control strategies and will discuss how adoption of new technology can rapidly advance intervention strategies. You can sign up for the presentation here even if you can’t make it to the event.
Kevin Giroux, Vice President of Sales and Marketing at Roka Bioscience will kick off the conference with opening remarks during the Keynote Session on Wednesday, May 10th at 9:15 AM.
Roka Bioscience will be at booth #405 in the exhibit hall for further discussions and follow up.
About Food Safety Summit
The Food Safety Summit is a solution-based conference and expo designed to meet the educational and informational needs of the food industry including growers, processors, retailers, distributors, foodservice operators, regulators, and academia. The Summit provides a 3-day comprehensive educational program to learn from subject matter experts, trainers, exchange ideas and find solutions to your current job challenges. The Summit has an expansive Exhibit Hall packed with progressive vendors and exclusive networking events to help you make meaningful industry connection. http://www.foodsafetysummit.com
About Roka Bioscience
Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result-out” Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://rokabio.com.
Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
SOURCE Roka Bioscience, Inc.